Literature DB >> 19321447

Tumor necrosis factor-alpha induces caspase-mediated cleavage of peroxisome proliferator-activated receptor gamma in adipocytes.

Adilson Guilherme1, Gregory J Tesz, Kalyani V P Guntur, Michael P Czech.   

Abstract

The nuclear receptor peroxisome proliferator-activated receptor gamma (PPARgamma) is a ligand-dependent transcription factor that acts as a primary regulator of adipogenesis and controls adipocyte metabolism and insulin action. Increased expression of tumor necrosis factor (TNFalpha) in adipose tissue of obese subjects potently suppresses the expression of PPARgamma and attenuates adipocyte functions. Here we show that PPARgamma is a substrate of caspase-3 and caspase-6 during TNFalpha receptor signaling in adipocytes, and the consequent PPARgamma cleavage disrupts its nuclear localization. TNFalpha treatment of 3T3-L1 adipocytes decreases full-length PPARgamma while increasing the level of a 45-kDa immunoreactive PPARgamma fragment. Specific inhibitors of caspase-3 and caspase-6 attenuate the cleavage of PPARgamma protein in response to TNFalpha in cultured adipocytes. Incubation of nuclear fractions with recombinant caspase-3 and caspase-6 also generates a 45-kDa PPARgamma cleavage product. Dispersion of nuclear PPARgamma to the cytoplasm in response to TNFalpha treatment occurs in parallel with detection of activated caspase-3. We suggest that activation of the caspase cascade by TNFalpha down-regulates PPARgamma protein and PPARgamma-mediated metabolic processes in adipose cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19321447      PMCID: PMC2719346          DOI: 10.1074/jbc.M809042200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

1.  Selective intranuclear redistribution of PPAR isoforms by RXR alpha.

Authors:  Taro E Akiyama; Christopher T Baumann; Shuichi Sakai; Gordon L Hager; Frank J Gonzalez
Journal:  Mol Endocrinol       Date:  2002-04

2.  Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone.

Authors:  Leanne Wilson-Fritch; Alison Burkart; Gregory Bell; Karen Mendelson; John Leszyk; Sarah Nicoloro; Michael Czech; Silvia Corvera
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

3.  Interferon-gamma-mediated activation and ubiquitin-proteasome-dependent degradation of PPARgamma in adipocytes.

Authors:  Z Elizabeth Floyd; Jacqueline M Stephens
Journal:  J Biol Chem       Date:  2001-11-30       Impact factor: 5.157

Review 4.  Lipotoxic diseases.

Authors:  Roger H Unger
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

5.  A PPARgamma mutant serves as a dominant negative inhibitor of PPAR signaling and is localized in the nucleus.

Authors:  J Berger; H V Patel; J Woods; N S Hayes; S A Parent; J Clemas; M D Leibowitz; A Elbrecht; R A Rachubinski; J P Capone; D E Moller
Journal:  Mol Cell Endocrinol       Date:  2000-04-25       Impact factor: 4.102

6.  Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory.

Authors:  Hong Ruan; Nir Hacohen; Todd R Golub; Luk Van Parijs; Harvey F Lodish
Journal:  Diabetes       Date:  2002-05       Impact factor: 9.461

7.  Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation.

Authors:  A Chawla; E J Schwarz; D D Dimaculangan; M A Lazar
Journal:  Endocrinology       Date:  1994-08       Impact factor: 4.736

8.  Tumor necrosis factor alpha inhibits signaling from the insulin receptor.

Authors:  G S Hotamisligil; D L Murray; L N Choy; B M Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

9.  Interaction between glucose and free fatty acid metabolism in human skeletal muscle.

Authors:  D E Kelley; M Mokan; J A Simoneau; L J Mandarino
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

10.  Obesity-induced inflammatory changes in adipose tissue.

Authors:  Kathryn E Wellen; Gokhan S Hotamisligil
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

View more
  17 in total

1.  Human Breast Cancer Xenograft Model Implicates Peroxisome Proliferator-activated Receptor Signaling as Driver of Cancer-induced Muscle Fatigue.

Authors:  Hannah E Wilson; Kacey K Rhodes; Daniel Rodriguez; Ikttesh Chahal; David A Stanton; Joseph Bohlen; Mary Davis; Aniello M Infante; Hannah Hazard-Jenkins; David J Klinke; Elena N Pugacheva; Emidio E Pistilli
Journal:  Clin Cancer Res       Date:  2018-12-17       Impact factor: 12.531

2.  Role of caspase-1 in regulation of triglyceride metabolism.

Authors:  Maya E Kotas; Michael J Jurczak; Charles Annicelli; Matthew P Gillum; Gary W Cline; Gerald I Shulman; Ruslan Medzhitov
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-04       Impact factor: 11.205

3.  High-fat diet triggers inflammation-induced cleavage of SIRT1 in adipose tissue to promote metabolic dysfunction.

Authors:  Angeliki Chalkiadaki; Leonard Guarente
Journal:  Cell Metab       Date:  2012-08-08       Impact factor: 27.287

4.  Caspases in metabolic disease and their therapeutic potential.

Authors:  Claire H Wilson; Sharad Kumar
Journal:  Cell Death Differ       Date:  2018-05-09       Impact factor: 15.828

5.  Egr-1 contributes to IL-1-mediated down-regulation of peroxisome proliferator-activated receptor γ expression in human osteoarthritic chondrocytes.

Authors:  Sarah-Salwa Nebbaki; Fatima Ezzahra El Mansouri; Hassan Afif; Mohit Kapoor; Mohamed Benderdour; Nicolas Duval; Jean-Pierre Pelletier; Johanne Martel-Pelletier; Hassan Fahmi
Journal:  Arthritis Res Ther       Date:  2012-03-28       Impact factor: 5.156

6.  Serum amyloid A is a growth factor for 3T3-L1 adipocytes, inhibits differentiation and promotes insulin resistance.

Authors:  F B Filippin-Monteiro; E M de Oliveira; S Sandri; F H Knebel; R C Albuquerque; A Campa
Journal:  Int J Obes (Lond)       Date:  2011-10-11       Impact factor: 5.095

7.  Adipose triglyceride lipase and hormone-sensitive lipase are involved in fat loss in JunB-deficient mice.

Authors:  Montserrat Pinent; Andreas Prokesch; Hubert Hackl; Peter J Voshol; Ariane Klatzer; Evelyn Walenta; Ute Panzenboeck; Lukas Kenner; Zlatko Trajanoski; Gerald Hoefler; Juliane G Bogner-Strauss
Journal:  Endocrinology       Date:  2011-05-03       Impact factor: 5.051

8.  TNF-α involvement in insulin resistance induced by experimental scorpion envenomation.

Authors:  Aouatef Ait-Lounis; Fatima Laraba-Djebari
Journal:  PLoS Negl Trop Dis       Date:  2012-07-17

9.  TRAIL (TNF-related apoptosis-inducing ligand) regulates adipocyte metabolism by caspase-mediated cleavage of PPARgamma.

Authors:  M Keuper; I Wernstedt Asterholm; P E Scherer; M-A Westhoff; P Möller; K-M Debatin; G Strauss; M Wabitsch; P Fischer-Posovszky
Journal:  Cell Death Dis       Date:  2013-01-24       Impact factor: 8.469

10.  Caspase induction and BCL2 inhibition in human adipose tissue: a potential relationship with insulin signaling alteration.

Authors:  Francisco José Tinahones; Leticia Coín Aragüez; Mora Murri; Wilfredo Oliva Olivera; María Dolores Mayas Torres; Nuria Barbarroja; Ricardo Gomez Huelgas; Maria M Malagón; Rajaa El Bekay
Journal:  Diabetes Care       Date:  2012-11-27       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.